Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

Vertex hepatitis C drug helps the hard-to-treatBusinessWeekVertex Pharmaceuticals Inc. said Tuesday that a late-stage clinical trial showed its hepatitis C drug candidate telaprevir proved effective for patients who ...See all stories on this topic »

Idenix hep C drugs on clinical hold; shares plummetReutersO) said US health regulators halted all trials of two of its experimental hepatitis C drugs on safety concerns, putting the breaks on a potential ...See all stories on this topic »

Bristol's Smart BuyForbes (blog)It helps Bristol-Myers Squibb play in the emerging hepatitis C market by giving the company full control of the drug the two firms were developing together. ...See all stories on this topic »

Idenix shares slump on hepatitis C drug commentsReuters... notice from the Food and Drug Administration that two of its experimental hepatitis C treatments have been put on clinical hold due to safety issues. ...See all stories on this topic »

First partnership conference on fight against hepatitis B and CEuropolitics.infoBy Sophie Petitjean | Tuesday 07 September 2010 The idea of setting up an international conference on hepatitis B and hepatitis C, which had encouraged ...See all stories on this topic »

Mayo Clinic Letter Leaves Patient TerrifiedWJXT villeA man who is one of 3209 patients who may be at risk of hepatitis C while at the Mayo Clinic said he's dealing with the very personal, private health matter ...See all stories on this topic »

Barclays, Oracle, Idenix Are Big MoversABC NewsThe biopharmaceutical said the FDA has placed testing of two potential Hepatitis C drugs on hold because of safety concerns. A BMO analyst expects more ...See all stories on this topic »

China Sky One, Idenix: Volume MoversTheStreet.com... notice from Food and Drug Administration that programs for advanced hepatitis C drug candidates IDX184 and IDX320 have been placed on clinical hold. ...See all stories on this topic »

New Patents Expand Coverage for Imaging and Therapeutic Applications of ...MarketWatch (press release)The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain ...See all stories on this topic »

Doctors say chimp research is superfluous, ethically costlyAlamogordo Daily News said he has also been exhaustively looking at hepatitis C and has written two papers that are coming out in the next several months. ...See all stories on this topic »